In contrast, the BKBA (52) compound functions by inhibiting the NF-κB and STAT proteins, which act both as signal transducers and as activators of transcription, and this compound may therefore be developed into a potential anti-cancer therapeutic agent in the future [43]. Here, NFKB1 is linked to cancer.